FDA Approves Symtuza, the First Complete Darunavir-Based, Single-Tablet Regimen for HIVBy mrvta - July 19, 2018Facebook Twitter Linkedin Email Print The FDA recently approved Janssen’s Symtuza, the first complete darunavir-based, single-tablet regimen for the treatment of HIV-1.
